|
|
 |
|
Viewing report
|
|
|
|
New Concepts in Cancer Therapeutics
Bioseeker, Dec 2005
In the world there are close to 25 million people living with cancer today, a figure that will probably increase to around 30 million people by 2020. This publication is one of the most extensive studies of novel concepts for fighting cancer.
Scope of this report
Global cancer trends
Global pipeline overview and clinical trial analysis
Current treatment of major cancer indications
Strategy and progress on new anticancer targets and drugs
Evolving screening technologies
Research and analysis highlights
There are, at present, ten times more anticancer drugs being tested in clinical trials than there were 20 years ago. Many of the new classes of agents, however, are predicted to work in only small subpopulations of patients, target unconventional aspects of tumour development and interact with other agents in an unpredictable manner. How can research and clinical trials be re-designed to accommodate the new features of targeted anticancer drugs? This publication reports on more than 100 companies and close to a 100 different anticancer drugs, where of 20 are new to the world in general.
Key reasons to read this report
Find out where the cancer market is going
Current status on drugs available to fight major cancer indications
Discover the very latest about new innovative anticancer drugs, and how they are made
Anticancer R&D strategies
Customers who bought this item also bought
Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Lung Cancer and Melanoma
Drug Delivery in Cancer - Technologies, Markets and Companies
Cancer Drug Resistance
Triple Progress Analysis: Lymphoma Therapeutics, Protein Kinase Inhibitors & Therapeutic Antibodies
Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Breast and Prostate Cancer
Triple Analysis: Non Small Cell Lung Cancer, Protein Kinase Inhibitors & Anti-Angiogenic Agents
Breast Cancer - Therapeutic And Competitive Insights
Prostate and Breast Cancer- New Treatments & Developmental Progress
The Cancer Clock
Anticancer Therapeutics
Antibody Drug Targets and Focus on Breast & Prostate Cancer
Targeted Therapeutics in Non-Small Cell Lung Cancer
|
|
|
|
